Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (121-130 of 329) with videos related to

Pageof 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasmaCathia Soulié, Roland Tubiana, Anne Simon, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophyGeneviève Chêne, Bahia Amellal, Gaëlle Pédrono, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2013
Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype BCathia Soulié, Sidonie Lambert-Niclot, Djenaba Bocar Fofana, et al.
Topics in Antiviral Medicine|June 5, 2025
2025 update of the drug resistance mutations in HIV-1Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, et al.
AIDS (London, England)|January 11, 2011
HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitisCathia Soulié, Slim Fourati, Sidonie Lambert-Niclot, et al.
AIDS (London, England)|June 17, 2005
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimenValérie Martinez, Anne-Geneviève Marcelin, Jean-Pierre Morini, et al.
The Journal of Infectious Diseases|January 6, 2007
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infectionPhilippe Flandre, Colombe Chappey, Anne Genevieve Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2009
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patientsIsabelle Malet, Olivier Delelis, Cathia Soulie, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2015
Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencingEve Todesco, Christophe Rodriguez, Laurence Morand-Joubert, et al.
Journal of Medical Virology|March 25, 2008
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrasesIsabelle Malet, Cathia Soulie, Luba Tchertanov, et al.
Pageof 33

Showing results (121-130 of 329) with videos related to

Sort By:
Pageof 33
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasmaCathia Soulié, Roland Tubiana, Anne Simon, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophyGeneviève Chêne, Bahia Amellal, Gaëlle Pédrono, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2013
Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype BCathia Soulié, Sidonie Lambert-Niclot, Djenaba Bocar Fofana, et al.
Topics in Antiviral Medicine|June 5, 2025
2025 update of the drug resistance mutations in HIV-1Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, et al.
AIDS (London, England)|January 11, 2011
HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitisCathia Soulié, Slim Fourati, Sidonie Lambert-Niclot, et al.
AIDS (London, England)|June 17, 2005
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimenValérie Martinez, Anne-Geneviève Marcelin, Jean-Pierre Morini, et al.
The Journal of Infectious Diseases|January 6, 2007
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infectionPhilippe Flandre, Colombe Chappey, Anne Genevieve Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|February 18, 2009
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patientsIsabelle Malet, Olivier Delelis, Cathia Soulie, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2015
Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencingEve Todesco, Christophe Rodriguez, Laurence Morand-Joubert, et al.
Journal of Medical Virology|March 25, 2008
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrasesIsabelle Malet, Cathia Soulie, Luba Tchertanov, et al.
Pageof 33